http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60213629-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
filingDate 2002-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e8470b25e958a5d856a0db31b489380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afabe4132e4fc910f8841120eca5000d
publicationDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60213629-T2
titleOfInvention Piperidin compounds as muscarinic agonists
abstract The present invention discloses compounds, which are novel muscarinic receptor antagonists, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such muscarinic receptor antagonists as well as methods for using them to treat cognitive disorders such as Alzheimer's disease.
priorityDate 2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397498
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1128
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574362
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403858
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81645
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465946243
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1129
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25229
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID794658
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12669
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID243764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281684
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID418126
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396364
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID522170
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID352938
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID483776

Total number of triples: 51.